esc semaglutide Weight Loss Treatment: GLP-1 Care Plan ESC 2024: Latest FLOW trial
Description
Studies have demonstrated that semaglutide is safe for use in both adult and elderly patients with renal or hepatic conditions, requiring no adjustment in dosage
The Trump administration's grand bargain with drugmakers isn't working out as planned.
Understanding these effects and planning discontinuation with provider guidance helps minimize disruption to metabolic health
* Which supplements help address potential nutritional gaps
PlexusDx helps identify and overcome these barriers to sustained weight loss
Melanie Davies, CBE, MBChB, MD, FRCP, FRCGP, FMedSci, and Vanita R
